Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
24.65
+0.21 (0.86%)
Mar 24, 2026, 11:08 AM EDT - Market open
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 8 analysts that cover Elanco Animal Health stock have a consensus rating of "Buy" and an average price target of $27.63, which forecasts a 12.09% increase in the stock price over the next year. The lowest target is $23 and the highest is $30.
Price Target: $27.63 (+12.09%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 5 | 6 | 7 | 7 | 6 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | -2.64% | Feb 25, 2026 |
| Keybanc | Keybanc | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +17.65% | Feb 25, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +21.70% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $24 → $28 | Buy | Maintains | $24 → $28 | +13.59% | Feb 19, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $24 → $30 | Hold → Buy | Upgrades | $24 → $30 | +21.70% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
5.12B
from 4.72B
Increased by 8.61%
Revenue Next Year
5.37B
from 5.12B
Increased by 4.90%
EPS This Year
1.05
from -0.47
EPS Next Year
1.18
from 1.05
Increased by 12.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.5B | 5.6B | |||
| Avg | 5.1B | 5.4B | |||
| Low | 4.9B | 5.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.4% | 9.2% | |||
| Avg | 8.6% | 4.9% | |||
| Low | 3.5% | -0.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.17 | 1.32 | |||
| Avg | 1.05 | 1.18 | |||
| Low | 0.97 | 1.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 25.8% | |||
| Avg | - | 12.4% | |||
| Low | - | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.